On September 16, the Angiogenesis Foundation released a white paper identifying the needs, challenges and proposed solutions in Canada for preventing vision loss from diabetes.
The white paper, “Advocating for Improved Treatment and Outcomes for Diabetic Macular Edema in Canada,” is the result of a multi-stakeholder expert summit convened in Toronto this past January by the Angiogenesis Foundation, including leading expert clinicians in the field, researchers, patients, and patient advocates. It identifies future goals and makes recommendations to be taken by advocacy leaders, ophthalmologists, optometrists and the diabetes community at large for improving vision outcomes in Canada.
The report can be downloaded here. It will also be distributed at the 15th Euretina Congress in Nice, France, taking place from 17-20 September.
